In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines
1999
Targeted Radiotherapy with Lipiodol for Liver and Colorectal Cancer
publication
Evidence: moderate
Author Information
Author(s): Al-Mufti R A M, Pedley R B, Marshall D, Begent R H J, Hilson A, Winslet M C, Hobbs K E F
Primary Institution: Royal Free Hospital
Hypothesis
The study evaluates the in vitro cytotoxic effects of 131I-Lipiodol on various cancer cell lines.
Conclusion
131I-Lipiodol showed marked cytotoxic effects on all cancer cell lines tested.
Supporting Evidence
- 131I-Lipiodol was cytotoxic against all the cancer cell lines tested.
- There were no cytotoxic effects from plain 131I in any of the cell lines.
- The cytotoxicity increased with higher radioactive doses.
Takeaway
This study found that a special treatment using Lipiodol can kill cancer cells in the lab, but it doesn't harm normal cells.
Methodology
The study exposed various cancer cell lines to 131I-Lipiodol for 48 hours and assessed cell counts and viability.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website